Jennifer Crombie, MD, Dana-Farber Cancer Institute, Boston, Massachusetts, discusses results from a real-world study of lisocabtagene maraleucel in patients with relapsed/refractory large B-cell lymphoma. Similar to published findings…
Tanya Siddiqi, MD, medical director of lymphoma, City of Hope, Orange County, California, discusses the primary analysis of the TRANSCEND CLL 004 trial. This phase 1/2, single-arm, multicenter…
52 months after a suggestive brain scan indicated a strong possibility of CTE in a former NFL player, the diagnosis has been confirmed by autopsy following the ex-players…
Eleanor K. Orehek, MD shares details of some new delivery methods for carbidopa/levodopa in patients with Parkinson’s disease. Among the promising new technologies are a credit card-sized wearable…
Researchers from University College London (UCL) are working on a project with the lofty goal of analyzing the entirety of a brain’s neuronal activity in real time. Most…
Irene Malaty, MD, Associate Professor of Neurology at the University of Florida, explains how doctors can help manage their patient’s motor fluctuations. A doctor can prescribe an alternative…
Charles Munyon, director of functional restorative neurosurgery at Temple University Hospital, MD, discusses movement disorders and their current treatments. Degenerative disorders involve the death of brain cells over…
Movement disorders aren’t always identified as irregular movements. Freezing in Parkinson’s disease (or motor block) happens when there is a brief temporary inability to move. Many patients with…
Neil Aronin, MD, is conducting studies that deal with how RNA interference interacts with the mutant gene in Huntington’s Disease. The research consists of inserting RNA into a…
